Form EFFECT Oncternal Therapeutics,

April 1, 2025 6:11 AM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 31, 2025
Accession Number: 0001193125-25-064597
Submission Type: POS AM
CIK: 0001260990
Company Name: Oncternal Therapeutics, Inc.
File Number: 333-204932


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings